New research suggests Alzheimer's drugs may improve cognition by increasing Aβ42 levels rather than just reducing plaques, ...
AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome ACI-24.060 was generally safe and well tolerated ...
Researchers have developed a novel computational pipeline designed to identify protein biomarkers associated with complex diseases, including Alzheimer's disease (AD). This innovative tool analyzes ...
A recent paper published in Nature Medicine sheds light on a remarkable case where Alzheimer's appears to have been medically ...